What Is ICSI?
The term “intracytoplasmic” describes the location of the sperm injection into the cytoplasm of an egg. This is the gel-like substance, made composed of water, salt, and other molecules, the centre of an egg.
The term “intracytoplasmic” describes the location of the sperm injection into the cytoplasm of an egg. This is the gel-like substance, made composed of water, salt, and other molecules, the centre of an egg.
Your healthcare professional must gather the eggs and sperm before performing ICSI.
The egg retrieval and sperm collection both happen on the same day unless you’re utilizing frozen sperm. Whoever is providing the sperm:
To determine sperm amount, motility, and quality, a semen analysis is performed right away. A sperm collection procedure like PESA and microscopic testicular sperm extraction might be necessary for people who have azoospermia, anejaculation, or retrograde ejaculation. This is also true for those who attempt a vasectomy reversal but fail. For use in clinic IVF procedures later, sperm may be frozen and stored in a laboratory.
ICSI is used in approximately 6 out of 10 IVF treatments. ICSI and conventional IVF both have the same success rates for conceiving a child. It is predicted that fertilization occurs in 50% to 80% of ICSI efforts.
The award-winning RoboICSI technology helps the embryologist during IVF to improve the results, assisting infertile couples in having a child. RoboICSI, a patent-pending product based on an innovative design methodology, will aid in bridging the supply and demand gaps in the rapidly expanding infertile market. It will be a Made in India product that will lead the way by introducing a number of features to the world.
It is a sophisticated equipment that makes it easier for the embryologist to execute ICSI. The holding pipette used in the traditional ICSI is replaced by RoboICSI.
In contrast to the conventional micro-pipette aspiration-based immobilisation, RoboICSI® provides a revolutionary method for capturing cells utilising biocompatible material, which has several advantages.
Even if the embryologist makes a mistake, RoboICSIclever ®’s passive force-limiting technology ensures that the oocyte is not harmed.
The devices now employed in ICSI workbenches were taken into consideration throughout the design and development of RoboICSI®. The plug-and-play technology of RoboICSI® enables the user to rapidly connect the system, carry out the auto-calibration, and get going in approximately a day.
Because RoboICSI® is simple to use, clinics may quickly integrate it into their workflow.
Copyrights © DYU Healthcare & Asthetics All Rights Reserve
Design and Development By : DigitalNock IT Solutions